| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/09/2007 | US20070185048 ATP-binding cassette transporter polypeptide which regulates metabolism of triglycerides; treatment of obesity and eating disorders |
| 08/09/2007 | US20070185043 Rna interference mediated inhibition of nogo and nogo receptor gene expression using short interfering nucleic acid (sina) |
| 08/09/2007 | US20070185042 Sirna based methods for treating alzheimer's disease |
| 08/09/2007 | US20070185036 4,5-bis(2-benzyloxyacetyloxy)-9,10-dioxo-9,10-dihydroanthracene-2-carboxylic acid, used as inhibitors of cytokine production and lymphocyte proliferation, for the treatment of inflammatory and autoimmune diseases; |
| 08/09/2007 | US20070185035 Enhanced mucosal administration of neuroprotective peptides |
| 08/09/2007 | US20070185034 acetyl-sarcosyl-glycyl-valyl-D-allo-isolucinyl-threoninyl-norvalyl-isolucinyl-arginyl-prolinyl-carboxylic acid; angiogensis inhibitors; anticancer agents |
| 08/09/2007 | US20070185033 Pharmaceutical formulations for sustained drug delivery |
| 08/09/2007 | US20070185032 Wter insolble complex of polypeptide and macromolecular carrier |
| 08/09/2007 | US20070185030 Immune response suppressor and treatment of multiple sclerosis |
| 08/09/2007 | US20070185029 specific polypeptide for pain management in human and plants ( post surgery pain; fever) |
| 08/09/2007 | US20070185028 Compositions and methods for treatment of protein misfolding and protein aggregation diseases |
| 08/09/2007 | US20070185027 Antiviral agents for the treatment, control and prevention of infections by coronaviruses |
| 08/09/2007 | US20070185026 Compositions and methods for treating bacteria |
| 08/09/2007 | US20070185025 Filoviral immunosuppressive peptides and uses thereof |
| 08/09/2007 | US20070185024 Systems and methods for screening for modulators of neural differentiation |
| 08/09/2007 | US20070185023 Developmental peptide; drug screening; cancer |
| 08/09/2007 | US20070185022 Therapeutic composiitons comprising bactericidal/permeability-increasing (BPI) protein products |
| 08/09/2007 | US20070185021 Diabetogenic epitopes |
| 08/09/2007 | US20070185020 Methods and compositions for treating disorders of the extracellular matrix |
| 08/09/2007 | US20070185019 Novel antimicrobial peptides with heparin binding activity |
| 08/09/2007 | US20070185018 Use of secretin in treatments of disorders associated with the amygdala |
| 08/09/2007 | US20070185017 Compositions and methods for the treatment of immune related diseases |
| 08/09/2007 | US20070185016 Treating a Staphylococcus aureus infection by administering an antibiotic and a cyclic peptide containing a unit from a synthetic or a biosynthetic amino acid which, after cyclization, contains a lactone, thiolactone, lactam or carbonyl-containing ring |
| 08/09/2007 | US20070185015 Semi-synthetic desmethyl-vancomycin-based glycopeptides with antibiotic activity |
| 08/09/2007 | US20070185014 Methods and compositions for modulating conjunctival goblet cells |
| 08/09/2007 | US20070185013 Use of chk1 inhibitors to control cell proliferation |
| 08/09/2007 | US20070185012 Glycopeptides for the treatment of als and other metabolic and autoimmune disorders |
| 08/09/2007 | US20070185011 Individual is not exposed to C1INH for longer than required, since levels of the C1INH more rapidly subsides after administration has stopped; side effect reduction |
| 08/09/2007 | US20070185010 Novel Polypeptide Hormone Phosphatonin |
| 08/09/2007 | US20070185009 Coated catheters |
| 08/09/2007 | US20070184523 Method for Making Multispecific Antibodies Having Heteromultimeric and Common Components |
| 08/09/2007 | US20070184522 Cell death modulation via antagonists of Fasl and Fas activation |
| 08/09/2007 | US20070184519 Peptides, polypeptides, and proteins of reduced immunogenicity and methods for their production |
| 08/09/2007 | US20070184517 Pharmacokinetics; glycosyltransferases; antibodies; immunoglobulins |
| 08/09/2007 | US20070184516 Method for the poduction of cyclic molecules |
| 08/09/2007 | US20070184493 Visualization and quantitation of cellular cytotoxicity using cell-permeable fluorogenic protease substrates and caspase activity indicator markers |
| 08/09/2007 | US20070184488 Beta-secretase substrates and uses thereof |
| 08/09/2007 | US20070184487 Compositions and methods for design of non-immunogenic proteins |
| 08/09/2007 | US20070184477 Anti-HIV Agent |
| 08/09/2007 | US20070184469 nine residue peptides (ApoptoM) from flavivirus M ectodomain able to modulate specifically the apoptotic activity of diverse flavivirus; use for the treatment and/or the prevention of flavivirus-linked infections and cancers |
| 08/09/2007 | US20070184461 Novel Polypeptide Hormone Phosphatonin |
| 08/09/2007 | US20070184126 Water-soluble bound matter of proanthocyandin and composition containing the same |
| 08/09/2007 | US20070184122 Fibronectin-modified ecm tissue graft constructs and methods for preparation and use thereof |
| 08/09/2007 | US20070184120 Adhesin-specific nanoparticles and process for using same |
| 08/09/2007 | US20070184118 Compositions and methods for oxalate reduction |
| 08/09/2007 | US20070184114 Formulation for topical non-invasive application in vivo |
| 08/09/2007 | US20070184084 Implantable elastomeric caprolactone depot compositions and uses thereof |
| 08/09/2007 | US20070184073 TB diagnostic based on antigens from M. tuberculosis |
| 08/09/2007 | US20070184070 Recombinant toxin fragments |
| 08/09/2007 | US20070184058 Glucocerebroside treatment of pulmonary or respiratory diseases or disorders |
| 08/09/2007 | US20070184052 Soluble tgf-b type III receptor fusion proteins |
| 08/09/2007 | US20070184046 Use of a phospholipase A2 for the preparation of pharmaceutical and/or cosmetic compositions for the local and/or systematic treatment and/or prevention of diseases and/or processes caused by intra- and extracellular pathogens expressing membrane phospholipids |
| 08/09/2007 | US20070184045 Large-Scale Production of Human Serum Butyrylcholinesterase as a Bioscavenger |
| 08/09/2007 | US20070184044 pkg inhibitor selected from KT5823; (Rp)-8-bromo-PET-cyclic GMPS (Guanosine 3',5'-cyclic Monophosphorothioate, ß-Phenyl-1,N 2 -etheno-8 -bromo-, Rp-Isomer); (Rp)-8-pCPT-cylic GMPS,TEA (Guanosine 3',5'-cyclic Monophosphorothioate, 8-(4 -Chlorophenylthio)-, Rp-Isomer, Triethylamine, fusion proteins |
| 08/09/2007 | US20070184043 Mammalian alpha-kinase proteins, nucleic acids and diagnostic and therapeutic uses thereof |
| 08/09/2007 | US20070184042 Method of cancer treatment by p53 protein control |
| 08/09/2007 | US20070184041 Methods and compositions related to production of coenzyme q10 |
| 08/09/2007 | US20070184040 Compositions for delivery of coenzyme Q10 |
| 08/09/2007 | US20070184034 Combination Pressure Therapy for Treatment of Hypertension, Blood Production, and Stem Cell Therapy |
| 08/09/2007 | US20070184027 Evacuating a clot from a blood vessel in a mammal; isolating a segment around evacuation site; infecting a segment of a blood vessel in vitro using a gutless adenoviral vector comprising a polynucleotide encoding a thrombomodulin protein or its variant; grafting the virus-treated blood vessel in mammal |
| 08/09/2007 | US20070184024 RNA polymerase, HCV metalloprotease, HCV serine protease, HCV polymerase, HCV helicase inhibitor; liver disease; (+/-)-8-Cyclohexyl-N-4-(morpholinosulfonyl)-1,1a,2,12b-tetrahydro-11-methoxy-1a-(3-methyl-3,8-diazabicyclo[3.2.1]octane-8-carbonyl)cycloprop[d]indolo[2,1-a][2]benzazepine-5-carboxamide |
| 08/09/2007 | US20070184023 Method for down-regulation of vegf |
| 08/09/2007 | US20070184022 Microsome vaccine |
| 08/09/2007 | US20070184021 Use of caspase inhibitors as a therapeutic agent against radiation-induced injury |
| 08/09/2007 | US20070184020 Combination of radio waves with pharmacologically active substances |
| 08/09/2007 | US20070184019 Pharmaceutical composition comprising an active principal and sulphobetaine |
| 08/09/2007 | US20070184015 Novel PEGylation agent |
| 08/09/2007 | US20070183983 Medical composition containing nf-kb decoy for treating and preventing respir atory diseases and method of using the same |
| 08/09/2007 | US20070183977 RGD peptide sequence; labelled with fluorescein used as contrast agents in optical imaging in diagnosis of angiogenesis-related diseases; peptidic vector and the fluorescein dye are coupled; cyclic peptide forming disulife or monothioether bridge |
| 08/09/2007 | US20070183975 Polypeptide absorbable into digestive organs |
| 08/09/2007 | US20070183974 Method and apparatus for production of a skin graft and the graft produced thereby |
| 08/09/2007 | US20070183971 Immunoconjugates targeting syndecan-1 expressing cells and use thereof |
| 08/09/2007 | US20070181124 Method and apparatus for dispensing inhalator medicament |
| 08/09/2007 | CA2643075A1 Thermally-targeted delivery of medicaments, including doxorubicin |
| 08/09/2007 | CA2641303A1 Na/k-atpase ligand |
| 08/09/2007 | CA2640531A1 Enterically coated cysteamine, cystamine and derivatives thereof |
| 08/09/2007 | CA2638887A1 Methods of treating degenerative disorders with rac 1b inhibitor |
| 08/09/2007 | CA2637836A1 Ang2 and vegf inhibitor combinations |
| 08/09/2007 | CA2637826A1 Methods for treating unwanted weight loss or eating disorders by administering a trkb agonist |
| 08/09/2007 | CA2637662A1 Drug-eluting intravascular prostheses and methods of use |
| 08/09/2007 | CA2635718A1 Methods of using hedgehog kinase antagonists to inhibit hedgehog signaling and to treat hedgehog mediated disorders |
| 08/08/2007 | EP1816201A1 Modified coagulation factor VIIa with extended half-life |
| 08/08/2007 | EP1816200A1 Postweaning multisystemic wasting syndrome virus for pigs |
| 08/08/2007 | EP1816199A1 Mutants of thyroid stimulating hormone and methods based thereon |
| 08/08/2007 | EP1816198A1 Variable fragments of immunoglobulins-use for therapeutic or veterinary purposes |
| 08/08/2007 | EP1816138A1 Cyclosporine analogue mixtures and their use as immunomodulating agents |
| 08/08/2007 | EP1816136A1 Gpr7-selective ligand and use thereof |
| 08/08/2007 | EP1815866A1 Remedy or preventive for ischemic cardiac disease or ischemic cardiac myopathy |
| 08/08/2007 | EP1815863A1 Use of TLR3 agonists for the treatment of neurodegenerative disorders |
| 08/08/2007 | EP1815862A1 Isolated stromal cells for use in the tretment of diseases of the central nervous system |
| 08/08/2007 | EP1815009A2 Method for designing polypeptides for the nanofabrication of thin films, coatings and microcapsules by electrostatic layer-by-layer self assembly. |
| 08/08/2007 | EP1814996A2 Polypeptides having antimicrobial activity and polynucleotides encoding same |
| 08/08/2007 | EP1814992A1 Gamma-delta t cell receptors |
| 08/08/2007 | EP1814991A1 Treatment of neurodegenerative diseases by the use of laptm4a |
| 08/08/2007 | EP1814989A2 Methods and compositions for rna interference |
| 08/08/2007 | EP1814977A1 Arthrospira-based compositions and uses thereof |
| 08/08/2007 | EP1814914A2 Antibodies that bind urokinase-type plasminogen activator and epitopes therefor |
| 08/08/2007 | EP1814913A2 Antibody induced cell membrane wounding |
| 08/08/2007 | EP1814905A1 Peptides derived from maurocalcine used as vectors for intracellular addressing of molecules of interest |
| 08/08/2007 | EP1814904A2 Antibiotic drosocin derivatives |